From: Three-dimensional surface imaging in breast cancer: a new tool for clinical studies?
 | baseline | week 3 | follow-up |
---|---|---|---|
Entire cohort (treated breast) | 379 ± 196 | 391 ± 198 | 437 ± 224 |
Entire cohort (untreated breast) | 382 ± 203 | 382 ± 205 | 382 ± 208 |
CF-RT (treated breast) | 387 ± 171 | 416 ± 183 | 443 ± 212 |
CF-RT (untreated breast) | 363 ± 174 | 370 ± 184 | 338 ± 160 |
HF-RT (treated breast) | 375 ± 211 | 379 ± 209 | 434 ± 236 |
HF-RT (untreated breast) | 392 ± 220 | 389 ± 220 | 404 ± 229 |